Navigant (NYSE: NCI) announced today that it has acquired substantially all of the Life Sciences practice of Leerink Swann Consulting, LLC, the consulting arm of Leerink Holdings, LLC, a leading investment bank specializing in healthcare. The addition of 20 professionals increases Navigant Healthcare’s deep bench of experts who serve clients in the fast changing, competitive and highly regulated life sciences industry.
“With increased complexities in the pharmaceutical, biotech, medical device, diagnostic and biomarkers markets, we believe that our collective experience and ability to understand current and future trends will be a timely asset to our clients,” said Eduardo Schur, Managing Director and leader of Navigant’s global Life Sciences practice. “The combination of the two consulting practices in the life sciences market strengthens our capabilities and scale to assist clients with their most challenging issues.”
Leerink Swann Consulting assists clients with business strategy development, opportunity assessment, due diligence, R&D portfolio management, new business planning, new product planning and related issues. Its professionals have established several longstanding client relationships with large pharmaceutical firms, specialty pharmaceutical companies, biotech firms and medical and diagnostic device companies.
“Navigant has made a significant commitment to growing its life sciences practice,” said Doug Martin, Managing Director of Leerink Swann Consulting. “Joining Navigant Healthcare’s Life Sciences practice provides a valuable platform for our consultants and access to a broader array of expertise for our clients.”No further details about the transaction were disclosed. About Navigant Healthcare Navigant Healthcare, a Navigant Consulting practice, works collaboratively across a spectrum of clients in the payer, provider and life sciences space. Our professionals consist of industry thought leaders, healthcare executives, clinicians, physicians and seasoned consultants who assist health systems, physician organizations, payers and life sciences companies in designing, developing and implementing integrated, technology-enabled solutions that create high-performing healthcare organizations. Navigant’s Life Sciences practice, a Navigant Healthcare subpractice, assists global life sciences companies in gaining competitive advantage by maximizing their business development, market access, strategic marketing, marketing research, brand management, and pricing and reimbursement initiatives. More information about Navigant Healthcare can be found at www.navigant.com/healthcare. More information about Navigant’s Life Sciences expertise can be found at www.navigant.com/lifesciences. About Navigant Navigant (NYSE: NCI) is a specialized, global expert services firm dedicated to assisting clients in creating and protecting value in the face of critical business risks and opportunities. Through senior level engagement with clients, Navigant professionals combine technical expertise in Disputes and Investigations, Economics, Financial Advisory and Management Consulting, with business pragmatism in the highly regulated Construction, Energy, Financial Services and Healthcare industries to support clients in addressing their most critical business needs. More information about Navigant can be found at www.navigant.com.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts